According to this article in bizjournals, Sanofi-Aventis will pay $95.5 million to settle a federal claim that accuses Aventis Pharmaceuticals Inc. of underpaying drug rebates it was required to pay into Medicaid between 1995 through 2000. The Justice Dept claims that $49 million of the settlement will be paid to the federal government, $40 million will be paid to the states, and the remaining $6 million will go to heath providers.
Read the full article here.
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
